1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Infectious Disease 1.2.3 Cancer 1.2.4 Others 1.3 Market by Application 1.3.1 Global mRNA Vaccine And Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Research Institual 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global mRNA Vaccine And Therapeutics Market Perspective (2016-2027) 2.2 mRNA Vaccine And Therapeutics Growth Trends by Regions 2.2.1 mRNA Vaccine And Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 mRNA Vaccine And Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 mRNA Vaccine And Therapeutics Industry Dynamic 2.3.1 mRNA Vaccine And Therapeutics Market Trends 2.3.2 mRNA Vaccine And Therapeutics Market Drivers 2.3.3 mRNA Vaccine And Therapeutics Market Challenges 2.3.4 mRNA Vaccine And Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue 3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2016-2021) 3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue 3.4 Global mRNA Vaccine And Therapeutics Market Concentration Ratio 3.4.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2020 3.5 mRNA Vaccine And Therapeutics Key Players Head office and Area Served 3.6 Key Players mRNA Vaccine And Therapeutics Product Solution and Service 3.7 Date of Enter into mRNA Vaccine And Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 mRNA Vaccine And Therapeutics Breakdown Data by Type 4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2022-2027) 5 mRNA Vaccine And Therapeutics Breakdown Data by Application 5.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America mRNA Vaccine And Therapeutics Market Size (2016-2027) 6.2 North America mRNA Vaccine And Therapeutics Market Size by Type 6.2.1 North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) 6.2.2 North America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) 6.2.3 North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2027) 6.3 North America mRNA Vaccine And Therapeutics Market Size by Application 6.3.1 North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) 6.3.2 North America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) 6.3.3 North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2027) 6.4 North America mRNA Vaccine And Therapeutics Market Size by Country 6.4.1 North America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) 6.4.2 North America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.3 Canada 7 Europe 7.1 Europe mRNA Vaccine And Therapeutics Market Size (2016-2027) 7.2 Europe mRNA Vaccine And Therapeutics Market Size by Type 7.2.1 Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2027) 7.3 Europe mRNA Vaccine And Therapeutics Market Size by Application 7.3.1 Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2027) 7.4 Europe mRNA Vaccine And Therapeutics Market Size by Country 7.4.1 Europe mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type 8.2.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application 8.3.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region 8.4.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America mRNA Vaccine And Therapeutics Market Size (2016-2027) 9.2 Latin America mRNA Vaccine And Therapeutics Market Size by Type 9.2.1 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2027) 9.3 Latin America mRNA Vaccine And Therapeutics Market Size by Application 9.3.1 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2027) 9.4 Latin America mRNA Vaccine And Therapeutics Market Size by Country 9.4.1 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type 10.2.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application 10.3.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country 10.4.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Argos Therapeutics 11.1.1 Argos Therapeutics Company Details 11.1.2 Argos Therapeutics Business Overview 11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction 11.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.1.5 Argos Therapeutics Recent Development 11.2 BioNTech 11.2.1 BioNTech Company Details 11.2.2 BioNTech Business Overview 11.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction 11.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.2.5 BioNTech Recent Development 11.3 CureVac 11.3.1 CureVac Company Details 11.3.2 CureVac Business Overview 11.3.3 CureVac mRNA Vaccine And Therapeutics Introduction 11.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.3.5 CureVac Recent Development 11.4 eTheRNA 11.4.1 eTheRNA Company Details 11.4.2 eTheRNA Business Overview 11.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction 11.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.4.5 eTheRNA Recent Development 11.5 Ethris 11.5.1 Ethris Company Details 11.5.2 Ethris Business Overview 11.5.3 Ethris mRNA Vaccine And Therapeutics Introduction 11.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.5.5 Ethris Recent Development 11.6 In-Cell-Art 11.6.1 In-Cell-Art Company Details 11.6.2 In-Cell-Art Business Overview 11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction 11.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.6.5 In-Cell-Art Recent Development 11.7 Moderna Therapeutics 11.7.1 Moderna Therapeutics Company Details 11.7.2 Moderna Therapeutics Business Overview 11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction 11.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.7.5 Moderna Therapeutics Recent Development 11.8 Sangamo Therapeutics 11.8.1 Sangamo Therapeutics Company Details 11.8.2 Sangamo Therapeutics Business Overview 11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction 11.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.8.5 Sangamo Therapeutics Recent Development 11.9 Tiba Biotechnology 11.9.1 Tiba Biotechnology Company Details 11.9.2 Tiba Biotechnology Business Overview 11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction 11.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.9.5 Tiba Biotechnology Recent Development 11.10 Translate Bio 11.10.1 Translate Bio Company Details 11.10.2 Translate Bio Business Overview 11.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction 11.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) 11.10.5 Translate Bio Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Infectious Disease Table 3. Key Players of Cancer Table 4. Key Players of Others Table 5. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global mRNA Vaccine And Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global mRNA Vaccine And Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global mRNA Vaccine And Therapeutics Market Share by Regions (2016-2021) Table 9. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global mRNA Vaccine And Therapeutics Market Share by Regions (2022-2027) Table 11. mRNA Vaccine And Therapeutics Market Trends Table 12. mRNA Vaccine And Therapeutics Market Drivers Table 13. mRNA Vaccine And Therapeutics Market Challenges Table 14. mRNA Vaccine And Therapeutics Market Restraints Table 15. Global mRNA Vaccine And Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 16. Global mRNA Vaccine And Therapeutics Market Share by Players (2016-2021) Table 17. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2020) Table 18. Ranking of Global Top mRNA Vaccine And Therapeutics Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by mRNA Vaccine And Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players mRNA Vaccine And Therapeutics Product Solution and Service Table 22. Date of Enter into mRNA Vaccine And Therapeutics Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 25. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2016-2021) Table 26. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global mRNA Vaccine And Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2016-2021) Table 30. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 33. North America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 34. North America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 35. North America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 36. North America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 37. North America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 39. Europe mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 41. Europe mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 62. Argos Therapeutics Company Details Table 63. Argos Therapeutics Business Overview Table 64. Argos Therapeutics mRNA Vaccine And Therapeutics Product Table 65. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 66. Argos Therapeutics Recent Development Table 67. BioNTech Company Details Table 68. BioNTech Business Overview Table 69. BioNTech mRNA Vaccine And Therapeutics Product Table 70. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 71. BioNTech Recent Development Table 72. CureVac Company Details Table 73. CureVac Business Overview Table 74. CureVac mRNA Vaccine And Therapeutics Product Table 75. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 76. CureVac Recent Development Table 77. eTheRNA Company Details Table 78. eTheRNA Business Overview Table 79. eTheRNA mRNA Vaccine And Therapeutics Product Table 80. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 81. eTheRNA Recent Development Table 82. Ethris Company Details Table 83. Ethris Business Overview Table 84. Ethris mRNA Vaccine And Therapeutics Product Table 85. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 86. Ethris Recent Development Table 87. In-Cell-Art Company Details Table 88. In-Cell-Art Business Overview Table 89. In-Cell-Art mRNA Vaccine And Therapeutics Product Table 90. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 91. In-Cell-Art Recent Development Table 92. Moderna Therapeutics Company Details Table 93. Moderna Therapeutics Business Overview Table 94. Moderna Therapeutics mRNA Vaccine And Therapeutics Product Table 95. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 96. Moderna Therapeutics Recent Development Table 97. Sangamo Therapeutics Company Details Table 98. Sangamo Therapeutics Business Overview Table 99. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 100. Sangamo Therapeutics Recent Development Table 101. Tiba Biotechnology Company Details Table 102. Tiba Biotechnology Business Overview Table 103. Tiba Biotechnology mRNA Vaccine And Therapeutics Product Table 104. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 105. Tiba Biotechnology Recent Development Table 106. Translate Bio Company Details Table 107. Translate Bio Business Overview Table 108. Translate Bio mRNA Vaccine And Therapeutics Product Table 109. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2016-2021) & (US$ Million) Table 110. Translate Bio Recent Development Table 111. Research Programs/Design for This Report Table 112. Key Data Information from Secondary Sources Table 113. Key Data Information from Primary Sources List of Figures Figure 1. Global mRNA Vaccine And Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Infectious Disease Features Figure 3. Cancer Features Figure 4. Others Features Figure 5. Global mRNA Vaccine And Therapeutics Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Research Institual Case Studies Figure 8. mRNA Vaccine And Therapeutics Report Years Considered Figure 9. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 10. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 11. Global mRNA Vaccine And Therapeutics Market Share by Regions: 2020 VS 2027 Figure 12. Global mRNA Vaccine And Therapeutics Market Share by Regions (2022-2027) Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Players in 2020 Figure 14. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in mRNA Vaccine And Therapeutics as of 2020 Figure 15. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2020 Figure 16. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2016-2021) Figure 17. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2022-2027) Figure 18. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 19. North America mRNA Vaccine And Therapeutics Market Share by Type (2016-2027) Figure 20. North America mRNA Vaccine And Therapeutics Market Share by Application (2016-2027) Figure 21. North America mRNA Vaccine And Therapeutics Market Share by Country (2016-2027) Figure 22. United States mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 23. Canada mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe mRNA Vaccine And Therapeutics Market Share by Type (2016-2027) Figure 26. Europe mRNA Vaccine And Therapeutics Market Share by Application (2016-2027) Figure 27. Europe mRNA Vaccine And Therapeutics Market Share by Country (2016-2027) Figure 28. Germany mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. France mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. U.K. mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. Italy mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Russia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Nordic mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Asia-Pacific mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Type (2016-2027) Figure 36. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Application (2016-2027) Figure 37. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Region (2016-2027) Figure 38. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. South Korea mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Australia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Latin America mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America mRNA Vaccine And Therapeutics Market Share by Type (2016-2027) Figure 46. Latin America mRNA Vaccine And Therapeutics Market Share by Application (2016-2027) Figure 47. Latin America mRNA Vaccine And Therapeutics Market Share by Country (2016-2027) Figure 48. Mexico mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Brazil mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Middle East & Africa mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Type (2016-2027) Figure 52. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Application (2016-2027) Figure 53. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Country (2016-2027) Figure 54. Turkey mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Saudi Arabia mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. UAE mRNA Vaccine And Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 58. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 59. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 60. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 61. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 62. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 63. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 64. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 65. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 66. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2016-2021) Figure 67. Bottom-up and Top-down Approaches for This Report Figure 68. Data Triangulation Figure 69. Key Executives Interviewed

Argos Therapeutics BioNTech CureVac eTheRNA Ethris In-Cell-Art Moderna Therapeutics Sangamo Therapeutics Tiba Biotechnology Translate Bio